In parallel, curated DDR gene panels (BRCA1/2, PALB2, ATM/CHEK2, RAD51 family) augmented by RCC-salient chromatin genes (SETD2, BAP1, PBRM1) may increase biological specificity. This evidence concerns the gene SETD2 and renal cell carcinoma.